Middle Cerebral Artery Peak Research Articles

Prenatal Manifestation of Transient Abnormal Myelopoiesis: Case Report and Review of the Literature.

Background: Congenital malignancies are unusual fetal conditions, and therefore, the data on their prenatal manifestation are limited. Transient abnormal myelopoiesis (TAM) is a hematologic disorder characteristic for babies with trisomy 21 and based on the transient appearance of blast cells in peripheral blood. Methods: This paper presents prenatal manifestation of congenital TAM in a newborn with normal karyotype and reviews the literature on prenatal manifestation of this disorder. Results: A pregnant woman in her third pregnancy referred herself to the hospital for reduced fetal movements at 30 weeks of gestation. Admission's ultrasound scan showed an increased middle cerebral artery peak systolic velocity together with hepatomegaly. The patient was admitted to the labor ward for cardiotocography monitoring which showed acute fetal distress with repeated unprovoked decelerations. An emergency cesarean section was conducted and a phenotypically normal female newborn with low Apgar score was delivered. Further examination of the peripheral blood revealed anemia and leukocytosis with high blast proportion. A bone marrow aspirate revealed 70.2% of blasts in a sample with an abnormal karyotype of 47 XX+21. Cytogenetic analysis of the blasts with later microarray comparative genomic hybridization confirmed the presence of GATA1 mutation. However, the buccal smear showed a normal karyotype in the infant. The disease was classified as TAM. Conclusions: Our study demonstrates a rare case of prenatal manifestation of TAM in a neonate with a normal karyotype. Obstetricians should pay attention to symptoms like high MCA PSV and hepatosplenomegaly as possible causes of fetal hematological disorders and differentiate it with infection or isoimmunization.

Elevated middle cerebral artery peak systolic velocity and risk of death in donor twin affected by twin-twin transfusion syndrome but not twin anemia-polycythemia sequence.

To determine the association between elevated (> 1.5 multiples of the median (MoM)) middle cerebral artery (MCA) peak systolic velocity (PSV) and fetal demise of the donor twin in pregnancies complicated by twin-twin transfusion syndrome (TTTS) in the absence of twin anemia-polycythemia sequence (TAPS). Secondary objectives were to evaluate if donor or recipient MCA-PSV is associated with a risk for their corresponding fetal death, and to compare the proportion of donor fetuses with low MCA pulsatility index (PI) among donor twins with high MCA-PSV and those with normal MCA-PSV to evaluate the contribution of blood-flow redistribution to the fetal brain in donor twins with high MCA-PSV. This prospective cohort study included TTTS cases that underwent laser surgery between 2011 and 2022 at a single center. TAPS cases were excluded from the study. Multivariable and Poisson regression analysis were performed to explore the association between isolated elevated donor MCA-PSV and fetal demise, adjusted for TTTS stage, selective fetal growth restriction (sFGR) and other confounders. Of 660 TTTS cases, donor MCA-PSV was not recorded in 48 (7.3%) cases. Of the remaining 612 patients, nine (1.5%) were lost to follow-up and 96 TAPS cases were excluded; thus, 507 cases were included in the study. High donor MCA-PSV was seen in 6.5% (33/507) of cases and was an independent risk factor for donor fetal demise (adjusted relative risk (aRR), 4.52 (95% CI, 2.72-7.50)), after adjusting for confounders. Regression analysis restricted to each Quintero TTTS stage demonstrated that high donor MCA-PSV was an independent risk factor for fetal demise of the donor in Quintero Stage II (aRR, 14.21 (95% CI, 1.09-186.2)) and Quintero Stage III (aRR, 3.41 (95% CI, 1.82-6.41)). Donor MCA-PSV in MoM was associated with fetal demise of the donor (area under the receiver-operating-characteristics curve (AUC), 0.69; P < 0.001), but recipient MCA-PSV in MoM was not associated with fetal demise of the recipient (AUC, 0.54; P = 0.44). A higher proportion of donor twins in the group with high MCA-PSV had a low MCA-PI compared to the group with normal MCA-PSV (33.3% vs 15.5%; P = 0.016). Elevated donor MCA-PSV without TAPS prior to laser surgery for TTTS is associated with a 4-fold increased risk for donor fetal demise, adjusted for sFGR, TTTS stage and other confounders. Doppler evaluation of donor MCA-PSV prior to laser surgery may help stratify TTTS staging to evaluate the risk of donor fetal demise. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.

Randomized controlled trial of twin-twin transfusion syndrome laser surgery: the sequential trial

Intraoperative blood transfer between twins during laser surgery for twin-twin transfusion syndrome can vary by surgical technique and has been proposed to explain differences in donor twin survival. This trial compared donor twin survival with 2 laser techniques: the sequential technique, in which the arteriovenous communications from the volume-depleted donor to the volume-overloaded recipient are laser-occluded before those from recipient to donor, and the selective technique, in which the occlusion of the vascular communications is performed in no particular order. A single-center, open-label, randomized controlled trial was conducted in which twin-twin transfusion syndrome patients were randomized to sequential vs selective laser surgery. Nested within the trial, a second trial randomized patients with superficial anastomoses (arterioarterial and venovenous) to ablation of these connections first (before ablating the arteriovenous anastomoses) vs last. The primary outcome measure was donor twin survival at birth. A total of 642 patients were randomized. Overall donor twin survival was similar between the 2 groups (274 of 320 [85.6%] vs 271 of 322 [84.2%]; odds ratio, 1.12 [95% confidence interval, 0.73-1.73]; P=.605). Superficial anastomoses occurred in 177 of 642 cases (27.6%). Donor survival was lower in the superficial anastomosis group vs those with only arteriovenous communications (125 of 177 [70.6%] vs 420 of 465 [90.3%]; adjusted odds ratio, 0.33 [95% confidence interval, 0.20-0.54]; P<.001). In cases with superficial anastomoses, donor survival was independent of the timing of ablation or surgical technique. The postoperative mean middle cerebral artery peak systolic velocity was lower in the sequential vs selective group (1.00±0.30 vs 1.06±0.30 multiples of the median; P=.003). Post hoc analyses showed 2 factors that were associated with poor overall donor twin survival: the presence or absence of donor twin preoperative critical abnormal Doppler parameters and the presence or absence of arterioarterial anastomoses. Depending on these factors, 4 categories of patients resulted: (1) Category 1 (347 of 642 [54%]), no donor twin critical abnormal Doppler+ no arterioarterial anastomoses: donor twin survival was 91.2% in the sequential and 93.8% in the selective groups; (2) Category 2 (143 of 642 [22%]), critical abnormal Doppler present+ no arterioarterial anastomoses: donor survival was 89.9% vs 75.7%; (3) Category 3 (73 of 642 [11%]), no critical abnormal Doppler+ arterioarterial anastomoses present: donor survival was 94.7% vs 74.3%; and (4) Category 4 (79 of 642 [12%]), critical abnormal Doppler present+ arterioarterial anastomoses present: donor survival was 47.6% vs 64.9%. Donor twin survival did not differ between the sequential vs selective laser techniques and did not differ if superficial anastomoses were ablated first vs last. The donor twin's postoperative middle cerebral artery peak systolic velocity was improved with the sequential vs the selective approach. Post hoc analyses suggest that donor twin survival may be associated with the choice of laser technique according to high-risk factors. Further study is needed to determine whether using these categories to guide the choice of surgical technique will improve outcomes.

Parvovirus B19 in Pregnancy.

Although the risk of parvovirus B19 infection during pregnancy and subsequent risk of adverse fetal outcome are low, understanding management practices is essential for proper treatment of fetuses with nonimmune hydrops fetalis. In addition, continued investigation into delivery management, breastfeeding recommendations, and congenital abnormalities associated with pregnancies complicated by parvovirus B19 infection is needed. This review describes the risks associated with parvovirus B19 infection during pregnancy and the management strategies for fetuses with vertically transmitted infections. Original articles were obtained from literature search in PubMed, Medline, and OVID; pertinent articles were reviewed. Parvovirus B19 is a viral infection associated with negative pregnancy outcomes. Up to 50% of people of reproductive age are susceptible to the virus. The incidence of B19 in pregnancy is between 0.61% and 1.24%, and, overall, there is 30% risk of vertical transmission when infection is acquired during pregnancy. Although most pregnancies progress without negative outcomes, viral infection of the fetus may result in severe anemia, congestive heart failure, and hydrops fetalis. In addition, vertical transmission carries a 5% to 10% chance of fetal loss. In pregnancies affected by fetal B19 infection, Doppler examination of the middle cerebral artery peak systolic velocity should be initiated to surveil for fetal anemia. In the case of severe fetal anemia, standard fetal therapy involves an intrauterine transfusion of red blood cells with the goal of raising hematocrit levels to approximately 40% to 50% of total blood volume. One transfusion is usually sufficient, although continued surveillance may indicate the need for subsequent transfusions. There are fewer epidemiologic data concerning neonatal risks of congenital parvovirus, although case reports have shown that fetuses with severe anemia in utero may have persistent anemia, thrombocytopenia, and edema in the neonatal period. Parvovirus B19 is a common virus; seropositivity in the geriatric population reportedly reaches 85%. Within the pregnant population, up to 50% of patients have not previously been exposed to the virus and consequently lack protective immunity. Concern for parvovirus B19 infection in pregnancy largely surrounds the consequences of vertical transmission of the virus to the fetus. Should vertical transmission occur, the overall risk of fetal loss is between 5% and 10%. Thus, understanding the incidence, risks, and management strategies of pregnancies complicated by parvovirus B19 is essential to optimizing care and outcomes. Further, there is currently a gap in evidence regarding delivery management, breastfeeding recommendations, and the risks of congenital abnormalities in pregnancies complicated by parvovirus B19. Additional investigations into optimal delivery management, feeding plans, and recommended neonatal surveillance are needed in this cohort of patients.

Diagnostic Accuracy of Fetal Middle Cerebral Artery Peak Systolic Velocity in the Detection of Fetal Anaemia Keeping Neonatal Hae Moglobin Estimation at Birth as the Gold Standard

Objective: To assess whether monitoring the peak systolic velocity (PSV) in the middle cerebral artery (MCA) was a useful, non-invasive method for predicting anaemia in fetuses. Study Design: Cross-sectional study Place and Duration of Study: Armed Forces Institute of Radiology, Rawalpindi Pakistan, from Feb and Aug 2022. Methodology: Fifty pregnant women who did not have hydropic babies were included. The peak systolic velocity (PSV) was measured in the middle cerebral artery (MCA). A positive result was determined when the MCA-PSV value exceeded 1.5multiples of the median (MoM). The blood samples obtained from neonates were forwarded to the hospital laboratory to estimate haemoglobin levels shortly after birth. The outcome of the method (MoM) was observed and subsequently compared with neonatal haemoglobin levels. Results: 60% of neonates were anaemic according to middle MCA-PSV while the haematology laboratory reported 74% of neonates as anaemic according to cut-off haemoglobin of less than 13.5gm/dl. Sensitivity, specificity, positive predictive value(PPV), negative predictive value (NPV), and accuracy of the MCA-PSV in detecting the anaemia were 93.75%, 61.1%, 81.08%, 84.62%, and 82%, respectively. Conclusion: MCA-PSV Doppler is deemed valuable as a diagnostic technique for fetal anaemia, albeit secondary to the primary approach of neonatal haemoglobin estimation upon birth.

Predictors of Poor Outcomes in Monochorionic Diamniotic Twin Pregnancies Complicated by Selective Fetal Growth Restriction

Introduction: The aim of the study was to identify predictors of poor outcomes in monochorionic diamniotic twin (MCDA) pregnancies with selective fetal growth restriction (sFGR), irrespective of the umbilical artery (UA) Doppler abnormalities. Methods: Single-center retrospective analysis of MCDA twins diagnosed with sFGR that opted for expectant management between 2010 and 2021. The presence of any of the following variables in the growth-restricted fetus: low amniotic fluid volume (DVP ≤2 cm), lack of a cycling bladder, absent or reversed flow in the ductus venosus (DV) with atrial contraction, and elevated middle cerebral artery peak systolic velocity (MCA-PSV) defined as ≥1.50 multiples of the median was categorized as complicated. sFGR cases were classified as simple in the absence of the above-mentioned variables. Results: Overall, 63.3% of cases qualified as simple, and 36.7% were complicated. Intertwin EFW discordance was higher in the complicated category (26 vs. 33%, p = 0.0002). The median gestational age at delivery was earlier (33 weeks vs. 30.5 weeks, p = 0.002), and the likelihood of survival was lower in the complicated category (p < 0.0001). The likelihood of two survivors to discharge was lower in type I complicated cases (70% in complicated type I vs. 97.1% in simple type I, p = 0.0003). On logistic regression analysis, an increase in the “complicated” score negatively correlated with two survivors to discharge (p < 0.0001). An ROC curve was created, and the AUC was 0.79. Increasing intertwin EFW discordance also decreased the probability of two survivors to discharge. Conclusion: The presence of oligohydramnios, lack of a cycling bladder, abnormal DV Doppler, and elevated MCA-PSV in the growth restricted fetus is associated with poor perinatal outcomes and a lower likelihood of having two survivors to discharge. The addition of intertwin EFW discordance to these variables helped improve the survival predictability.

Rhesus alloimmunization in pregnancy. A Tertiary Care Center Experience in Kenya. A Case Report

Background: Rhesus alloimmunization is a significant cause of perinatal morbidity in sub-SaharanAfrica.Case presentation: A 28-year-old para 2+2 gravida 5, rhesus-negative mother with no living childpresented to the Kenyatta National Hospital (KNH) antenatal clinic at 20 weeks of gestation as a referralbecause of a bad obstetric history secondary to rhesus D alloimmunization following a positive indirectCoombs test. She was started on methylprednisolone, and serial middle cerebral artery peak systolicvelocity (MCA-PSV) monitoring was performed until 32 weeks of gestation when the fetus developedhemolytic disease of the newborn diagnosed via cordocentesis. She underwent two sessions ofintrauterine transfusion and had a successful cesarean delivery at 34 weeks and 1 day of gestation. Theneonate was admitted to the KNH neonatal intensive care unit where he was managed for hemolyticdisease of the newborn, 33 days after which he was successfully discharged home.Conclusion: The role of maternal-fetal specialists in the diagnosis, antenatal follow-up, and timelymanagement of rhesus D alloimmunization is key in the prevention of adverse perinatal outcomes.

Massive fetomaternal hemorrhage: A case report.

We present a case with an incidental finding of abnormal cardiotocography (CTG) pattern as well as elevated middle cerebral artery peak systolic velocity (MCA-PSV) in an otherwise inconspicuous pregnancy. Massive fetomaternal hemorrhage (FMH) was detected as the cause by flow cytometry (FC), resulting in multiple cycles of fetal blood sampling (FBS) showing severe anemia, intrauterine transfusions (IUTs), a preterm delivery, and a healthy infant in follow-up examinations.

Middle cerebral artery peak systolic velocity monitoring of fetal anemia during chemotherapy in pregnancy.

Chemotherapy during pregnancy can increase the risk of fetal anemia. Severe fetal anemia can lead to the development of hydrops fetalis and potentially fetal demise. Hence, it is imperative to implement consistent monitoring methods in the context of chemotherapy treatment. This study aimed to diagnose and monitor fetal anemia using middle cerebral artery peak systolic velocity (MCA-PSV) as a diagnostic tool during chemotherapy in pregnant women. The study employed a prospective analysis involving a case series of 15 patients diagnosed with cancer during pregnancy and subsequently underwent chemotherapy. MCA-PSV was used to identify fetal anemia. The patients were scheduled for ultrasound examinations of the MCA-PSV. The first examination was performed on the same day as the administration of chemotherapy, while the second occurred on the 10th day after chemotherapy. The measurement technique used in the study was based on the methodology proposed by Mari and Barr. The multiples of the median were calculated using the calculators provided by Medicina Fetal Barcelona. Based on these values anemia severity was determined. When moderate or severe anemia was identified, chemotherapy was individually modified. Additionally, a blood count analysis was conducted immediately after the delivery of the newborn. Five patients were diagnosed with fetal or newborn anemia. With MCA-PSV, we identified moderate fetal anemia in two patients and severe fetal anemia in one. The complete blood count testing of newborns revealed mild anemia in three patients. One case was unrelated to chemotherapy-induced anemia. During treatment, fetal anemia did not corelate with maternal anemia. In four cases of anemia the combination of cisplatin and iphosphamide was used as a chemotherapy agent. No anemia was observed in other drug combinations. Our findings suggest that MCA-PSV is a reliable method for identifying anemia and should be included in the treatment protocol for chemotherapy-induced fetal anemia.

Prevalence of unexpected red blood cell antibodies in pregnant women and follow-up of pregnancy outcome in pregnant women treated with intra-uterine transfusion.

For the management of hemolytic disease of the fetus and newborn (HDFN), it is important to detect unexpected red cell antibody in pregnant women. We assessed the prevalence of unexpected red cell antibodies in consecutive pregnant women attending antenatal clinic (ANC). More importantly, cases with unexpected antibody causing severe anemia were followed-up for intervention (Intra-uterine transfusion {IUT}) and outcome of pregnancy (still-birth/live-healthy). The study was conducted with an objective to find the prevalence of unexpected RBC antibodies in pregnant women, their specificity and to do the follow-up for IUT and outcome of pregnancy (still-birth, live-birth) in antibody positive women. This was a prospective study from January 2021 to May 2022 at two tertiary care centres. All antenatal samples received by the laboratory were screened for unexpected red cell antibody. Whenever antibody screen was positive, antibody identification was performed. Patients, positive for unexpected antibody and anemia were followed up for any transfusion-based intervention and outcome of pregnancy. A total of 539 consecutive samples were worked up and among these, 10 samples (1.85%) were found to be antibody positive. The antibodies identified were Anti-D (n=6), anti-Leb (n=1), anti-M (n=1), anti-C (n=1) and anti-E (n=1).The prevalence of unexpected antibodies in Rh positive and Rh negative pregnant women was 0.83% and 10.9% respectively. Follow-up was done for all 10 cases with unexpected antibody and anemia was monitored by MCA PSV (middle cerebral artery peak systolic velocity).Two women developed severe anemia thus requiring single intrauterine transfusion (at 26 weeks and 28 weeks respectively) each, for correction of anemia. In both these cases, healthy male child was delivered. At 3-month follow-up both children were alive and healthy. The study found prevalence of unexpected RBC antibodies in pregnant women as 1.85%. The study also underlined importance of transfusion-based interventions contributing to successful outcome in couple of cases with severe anemia.

375 Elevated middle cerebral artery peak systolic velocity (MCA PSV) in fetuses with unexplained anemia

375 Elevated middle cerebral artery peak systolic velocity (MCA PSV) in fetuses with unexplained anemia

Latrogenic twin anemia: polycythemia sequence post-amnioreduction in twin-twin transfusion syndrome

We present a case of Iatrogenic twin anemia–polycythemia sequence (TAPS) post-amnioreduction in twin-twin transfusion syndrome at 32 gestational weeks. Slight middle cerebral artery (MCA) peak systolic velocity (PSV) discrepancy was present 3 days after the amnioreduction, with MCA PSV around 1.5 MoM of the doner and 1.0 MoM of the recipient. Eighteen days after the amnioreduction, though MCA PSV remained stable, placental dichotomy, starry-sky liver of the recipient and small amount of right pleural effusion of donor were noted. TAPS was diagnosed and postnatal examination of the twins and the placenta confirmed it. We conjectured that the decompression of the placenta after the sudden reduction of amniotic fluid volume may cause the patency of the tiny anastomoses, resulting in the TAPS.

Accuracy of a portable hemoglobinometer (HemoCue) to measure fetal hemoglobin values during in utero transfusion

Objectives The current recommended treatment for severe fetal anemia is in utero transfusion (IUT). During this procedure, the evaluation of the necessary volume of transfused blood is based on regular measurement of fetal hemoglobin (FHb) concentration. The gold standard measurement is performed in the biology laboratory. A rapid medical test such as HemoCue® is an effective way to predict FHb concentration. It would reduce the time to obtain results and therefore the procedure duration. To evaluate the accuracy of HemoCue® to measure FHb during IUT, we compared Hb levels obtained by HemoCue® and by our biology laboratory. Methods This retrospective study involved all pregnant women who had undergone an IUT in the university hospital of Clermont-Ferrand, France, during the period from 1 January 2010 to 6 June 2021. The FHb level was evaluated by two methods, a rapid medical test, HemoCue®, and a standard method in the biology laboratory. Results We obtained 244 pairs of results from HemoCue® and our laboratory, of 90 IUT procedures. The correlation between the two sets of results was excellent, with Lin’s concordance correlation coefficient of 0.979. However, we established that the measurements were not significantly modified by IUT number, puncture time, cause of fetal anemia, estimated fetal weight, gestational age, and delay between two IUT or middle cerebral artery peak systolic velocity values. Conclusion Our results allowed to extend the relevance of FHb measurements by HemoCue® during IUT.

Middle Cerebral Artery Blood Flow Velocity During Normal Pregnancy.

The present study aimed to evaluate resting middle cerebral artery (MCA) blood flow velocities using transcranial Doppler ultrasound (TCD) in healthy women at different stages of pregnancy, and to compare these velocities with those of normal controls. A total of 105 healthy normotensive pregnant women and 25 non-pregnant healthy controls were included in the study. We formed 3 groups according to gestational age: first trimester (7 to 13wk pregnant), second trimester (14 to 28wk pregnant), and third trimester (29 to 42wk pregnant). Age, body mass index, heart rate, arterial blood pressure, and hematological data were recorded and TCD was performed on the subjects. Regarding TCD, we evaluated the mean cerebral blood flow velocity, the peak systolic velocity, the end-diastolic flow velocity, S/D ratio, the pulsatility Index (PI) and the resistance Index (RI). The MCA mean blood flow velocities differed significantly among the groups (P<0.001) and were higher in the controls than those of the first trimester, second trimester, and third trimester groups (P<0.01, P<0.001, P<0.001 respectively). The MCA mean and peak blood flow velocities, and the PI and RI decreased significantly with advancing gestation. TCD is a noninvasive and non-toxic method of monitoring the adaptation of the maternal cerebral blood flow in pregnancy. The progressive decreases in the MCA mean and peak blood flow velocities, PI, and RI during gestation may be the result of chemical and neuronal factors. This study supports the need for additional studies using TCD to establish normative cerebral blood flow volumes throughout pregnancy.

Subclassification of fetal growth restriction type IIa vs type IIb applied to twin-twin transfusion syndrome

Subclassification of monochorionic twins with selective fetal growth restriction (sFGR) type II into IIa vs. IIb has been proposed due to differing neonatal survival outcomes of the growth-restricted fetus after laser surgery based on preoperative Doppler findings in the middle cerebral artery (MCA) and ductus venosus (DV). There is substantial clinical overlap between sFGR and twin-twin transfusion syndrome (TTTS). To compare donor twin neonatal survival after laser surgery in cases of TTTS with concomitant donor FGR type IIa vs. IIb. This is a retrospective study of monochorionic multifetal gestations treated with laser for Stage III TTTS and concomitant donor twin FGR type II at a referral center from 2006-2021. Donor FGR type II was defined as having an estimated fetal weight (EFW) <10th percentile with persistent absent and/or reversed end diastolic velocity in the umbilical artery. Patients were then subclassified as type IIa (having normal MCA peak systolic velocities [psv] and DV Doppler waveforms) vs. type IIb (having MCA psv ≥1.5 multiples of the median and/or DV with persistent absent or reversed atrial systolic flow). We compared 30-day neonatal survival of the donor twin by FGR type IIa vs. IIb using logistic regression to adjust for relevant preoperative covariates (p<0.10 in bivariate analysis). Of 919 patients who underwent laser surgery for TTTS, 262 had Stage III donor or donor/recipient TTTS; of these, 189 (20.6%) had concomitant donor FGR type II. Twelve met exclusion criteria, yielding 177 patients (19.3%) who comprised the study cohort. Patients were subclassified as donor FGR type IIa (146 [82%]) vs. type IIb (31 [18%]). Donor neonatal survival for FGR type IIa vs. IIb was 71.2% vs. 41.9% (p=0.003). Recipient neonatal survival did not differ between the two types (p=1.000). Patients classified with TTTS and concomitant donor FGR type IIb were 66% less likely to have neonatal survival of the donor after laser surgery (adjusted OR=0.34, 95% CI 0.15-0.80; p=0.0127). The logistic regression model was adjusted for gestational age at the procedure, EFW percent discordance, and nulliparity. The c-statistic was 0.702. For patients with Stage III TTTS and concurrent donor FGR with persistent absent or reversed end diastolic velocity in the umbilical artery (i.e., FGR type II), subclassification into FGR type IIb based on elevated MCA psv and/or abnormal DV flow in the donor conveyed poorer prognosis. Although donor neonatal survival after laser surgery was lower for Stage III TTTS patients with donor FGR type IIb compared with type IIa, laser surgery for FGR type IIb in the setting of TTTS (as opposed to pure sFGR type IIb) still allows for the possibility of dual survivorship and should be offered with shared decision-making when counseling patients on management options.

Early cerebral hemodynamic changes following unilateral carotid artery stenting in patients with different degrees of carotid stenosis.

Few studies have focused on cerebral hemodynamics in the early stage following carotid artery stenting (CAS). This retrospective cohort study aimed to investigate cerebral hemodynamic changes within 6 hours of unilateral CAS in patients with different degrees of carotid stenosis. A total of 104 patients who underwent CAS accompanied by transcranial color-code Doppler or transcranial Doppler were enrolled in the study. The participants were divided into the following 3 groups based on the degree of carotid stenosis: severe stenosis group, extreme stenosis group, and near occlusion group. Bilateral middle cerebral artery (MCA) peak systolic velocity (PSV) and pulsatility index (PI) were measured using transcranial color-code Doppler before and 1 and 3 hours following CAS. Blood pressure, MCA-PSV, and PI were compared among the 3 groups. At 1 hour following CAS, ipsilateral MCA-PSV increased compared to the baseline in the severe stenosis group [84±21 vs. 93±27 cm/s; 8.1%; interquartile range (IQR), 1.4-20.1%; P<0.001]. A similar hemodynamic change, but of a larger magnitude, was observed in the extreme stenosis group (83±24 vs. 100±29 cm/s; 20.8%; IQR, 5.3-33.1%; P<0.001) and near occlusion group (73±24 vs. 109±29 cm/s, 45.8%; IQR, 24.3-73.1%; P<0.001). At 3 hours after CAS, the hemodynamic changes were the same as those at 1 hour. PI increased in all 3 groups following CAS. A subgroup analysis was performed according to symptoms, sex, smoking status, history of hypertension, and presence of hyperlipidemia or diabetes, and the increase in ipsilateral MCA-PSV was not significant. In terms of adverse events, only 4 patients in the near occlusion group experienced transient post-CAS hyperperfusion. The ipsilateral MCA-PSV and PI in patients following unilateral CAS increased significantly in the initial hours. The increase in ipsilateral MCA-PSV was considerably higher in patients with a severe degree of stenosis. Near occlusion of the carotid artery was an independent risk factor for hyperperfusion after unilateral CAS.

It is time to include an image quality evaluation in alloimmunized mothers undergoing Doppler ultrasound assessment of middle cerebral artery peak systolic velocity?

digitalData = {"site":{"ip":"104.144.89.240","environment":"LIVE","website":"onlinelibrary.wiley.com","websiteCode":"pericles","serverDate":"2023-03-10"},"identities":[{"type":"RegionUser","uuid":"18971d33-e3f1-4194-be84-47668d10cf64"},{"type":"SmartGroupUser","uuid":"b238ab85-6bb4-49e4-84ca-a0d9f3ee5a35"},{"type":"SmartGroupUser","uuid":"b7acda8c-ce18-451b-a68d-e14b72f9b5b8"},{"type":"SmartGroupUser","uuid":"b2dbfe27-ecae-4bb6-bb0d-d75e5caa3762"},{"type":"SmartGroupUser","uuid":"da88d808-3f7b-4bde-9210-10862b6d121b"},{"type":"SmartGroupUser","uuid":"8c72a733-117a-4bc9-a682-13475f13e6a3"},{"type":"RegionUser","uuid":"3c5060a1-6620-438f-862b-902a4d4cd4ac"}],"publication":{"item":{"title":"It is time to include an image quality evaluation in alloimmunized mothers undergoing Doppler ultrasound assessment of middle cerebral artery peak systolic velocity?","doi":"10.1002/jcu.23372","access":"no","earliestDate":"2023-03-09","formats":["Full text","PDF","References","AM pdf"],"topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"PHYSICS","topicUri":"ph"},{"taxonomyUri":"global-subject-codes","topicLabel":"Gastroenterology & Hepatology","topicUri":"md90"},{"taxonomyUri":"global-subject-codes","topicLabel":"Gastroenterology","topicUri":"md91"},{"taxonomyUri":"global-subject-codes","topicLabel":"Urology","topicUri":"mdw0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Physics of Acoustics","topicUri":"ph51"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cardiovascular Disease","topicUri":"md40"},{"taxonomyUri":"global-subject-codes","topicLabel":"Classical & Fluid Mechanics","topicUri":"ph50"},{"taxonomyUri":"global-subject-codes","topicLabel":"Radiology & Imaging","topicUri":"mdp0"},{"taxonomyUri":"global-subject-codes","topicLabel":"General & Introductory Medical Science","topicUri":"md00"},{"taxonomyUri":"global-subject-codes","topicLabel":"Ultrasound","topicUri":"mdp2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pediatrics","topicUri":"mdl0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Neonatology","topicUri":"mdl1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Obstetrics & Gynecology","topicUri":"mdg0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Neurology","topicUri":"mdf0"}]},"group":{"title":"","doi":"10.1002/jcu.v51.3","access":"no","volume":"51","issue":"3","coverDate":"2023-03-01","topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"PHYSICS","topicUri":"ph"},{"taxonomyUri":"global-subject-codes","topicLabel":"Gastroenterology & Hepatology","topicUri":"md90"},{"taxonomyUri":"global-subject-codes","topicLabel":"Gastroenterology","topicUri":"md91"},{"taxonomyUri":"global-subject-codes","topicLabel":"Urology","topicUri":"mdw0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Physics of Acoustics","topicUri":"ph51"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cardiovascular Disease","topicUri":"md40"},{"taxonomyUri":"global-subject-codes","topicLabel":"Classical & Fluid Mechanics","topicUri":"ph50"},{"taxonomyUri":"global-subject-codes","topicLabel":"Radiology & Imaging","topicUri":"mdp0"},{"taxonomyUri":"global-subject-codes","topicLabel":"General & Introductory Medical Science","topicUri":"md00"},{"taxonomyUri":"global-subject-codes","topicLabel":"Ultrasound","topicUri":"mdp2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pediatrics","topicUri":"mdl0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Neonatology","topicUri":"mdl1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Obstetrics & Gynecology","topicUri":"mdg0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Neurology","topicUri":"mdf0"}]},"series":{"title":"Journal of Clinical Ultrasound","doi":"10.1002/(ISSN)1097-0096","access":"no","code":"10970096","issn":"0091-2751","eissn":"1097-0096","topics":[{"taxonomyUri":"gpt-sitename","topicLabel":"wly.radiol.imag_000105","topicUri":"wly.radiol.imag_000105"},{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"PHYSICS","topicUri":"ph"},{"taxonomyUri":"global-subject-codes","topicLabel":"Gastroenterology & Hepatology","topicUri":"md90"},{"taxonomyUri":"global-subject-codes","topicLabel":"Gastroenterology","topicUri":"md91"},{"taxonomyUri":"global-subject-codes","topicLabel":"Urology","topicUri":"mdw0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Physics of Acoustics","topicUri":"ph51"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cardiovascular Disease","topicUri":"md40"},{"taxonomyUri":"global-subject-codes","topicLabel":"Classical & Fluid Mechanics","topicUri":"ph50"},{"taxonomyUri":"global-subject-codes","topicLabel":"Radiology & Imaging","topicUri":"mdp0"},{"taxonomyUri":"global-subject-codes","topicLabel":"General & Introductory Medical Science","topicUri":"md00"},{"taxonomyUri":"global-subject-codes","topicLabel":"Ultrasound","topicUri":"mdp2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pediatrics","topicUri":"mdl0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Neonatology","topicUri":"mdl1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Obstetrics & Gynecology","topicUri":"mdg0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Neurology","topicUri":"mdf0"},{"taxonomyUri":"gpt-zonename","topicLabel":"j-clin-ultras_JCU","topicUri":"j-clin-ultras_jcu"}]}},"page":{"subPage":"Abstract","page":"Article/Chapter View","pageGroup":"Publication Pages","title":"title","errorCode":200}}

Suspected twin anemia polycythemia sequence in a dichorionic, diamniotic twin pregnancy: a case report

BackgroundTwin anemia polycythemia sequence is a rare complication in monochorionic twin pregnancy.Case presentationWe describe a case of dichorionic twin pregnancy presenting with suspected twin anemia polycythemia sequence. A 31-year-old White female, on her third pregnancy, had a routine ultrasound scan at 12 weeks gestation, which demonstrated a dichorionic twin pregnancy with one placenta located in the anterior wall and the other in the posterior wall of the uterus. At 21 weeks, a scan demonstrated a 24% growth discordance between the two fetuses with normal Doppler studies and amniotic fluid. At 27 weeks, one twin showed signs of anemia and the other polycythemia; the fetal middle cerebral artery peak systolic velocity was high in the anemic fetus and low in the polycythemic twin (1.8 and 0.5 multiples of the median). An intrauterine blood transfusion was carried out and this increased the fetal hemoglobin concentration in the anemic twin from 3.5 to 12.5 g/dL. At 29 weeks, delivery by cesarean section was carried out because of evidence from middle cerebral artery peak systolic velocity of recurrence of anemia in one twin and worsening polycythemia in the co-twin; at birth the hemoglobin concentrations were 5.6 and 24.9 g/dL, respectively. Histopathological examination confirmed dichorionicity with no communicating vessels between the two placentas.ConclusionsThis is the first case of twin anemia polycythemia sequence in a dichorionic, diamniotic twin pregnancy where intrauterine blood transfusion was used to prolong the pregnancy by almost 2 weeks in a “twin anemia polycythemia sequence-like” setting.

75-g oral glucose tolerance testing does not affect fetal cardiac doppler parameters in low-risk pregnant women

The study aimed to examine whether acute hyperglycemia, caused by the 75-g oral glucose tolerance test (OGTT) can produce fetal cardiac adverse effects that are detectable with fetal cardiac Doppler ultrasound in healthy low-risk pregnancies. Healthy low-risk pregnant women who underwent 75-g OGTT during the gestational period of 24 to 28 weeks were considered eligible and during the test, they were examined with fetal ultrasound at the fasting and 1- and 2-h timepoints. The study findings included the parameters of umbilical artery pulsatility index, uterine artery, fetal heart rate, middle cerebral artery (MCA) peak systolic velocity (MCA-PSV), MCA pulsatility index, and fetal cardiac Doppler parameters including myocardial performance index, left isovolumetric contraction and relaxation times, K-index, filling time, mitral E- and A-wave velocities, and E/A ratio. The data of 53 women without gestational diabetes mellitus were used for statistical analyses. There was no statistical significance among the three-time points of OGTT regarding all the Doppler parameters (p&gt;0.05). The median MCA-PSV measured at the fasting of OGTT was significantly higher than the values measured at the first and second hour of OGTT [28 (22-42) vs. 26 (18-39) and 26 (18-38), respectively; p&lt;0.05]. This increase provided no relationship with other study parameters (p&gt;0.05). Overall, 75-g OGTT does not affect fetal cardiac Doppler parameters in healthy pregnant women except for abnormal findings of MCA-PSV. The results of the current study can provide significant support to clinicians in reducing the hesitations of women with low-risk pregnancies regarding gestational diabetes screening.

The Value of Delta Middle Cerebral Artery Peak Systolic Velocity for the Prediction of Twin Anemia-Polycythemia Sequence-Analysis of a Heterogenous Cohort of Monochorionic Twins.

Twin anemia-polycythemia sequence (TAPS) is a complication in monochorionic-diamniotic (MCDA) twin pregnancies. This study analyzes whether the prenatal diagnosis using delta middle cerebral artery-peak systolic velocity (MCA-PSV) &gt; 0.5 multiples of the median (MoM) (delta group) detects more TAPS cases than the guideline-based diagnosis using the MCA-PSV cut off levels of &gt;1.5 and &lt;1.0 MoM (cut-off group), in a heterogenous group of MCDA twins. A retrospective analysis of 348 live-born MCDA twin pregnancies from 2010 to 2021 with available information on MCA-PSV within one week before delivery and hemoglobin-values within 24 h postnatally were considered eligible. Among postnatal confirmed twin pairs with TAPS, the cut-off group showed lower sensitivity than the delta group (33% vs. 82%). Specificity proved higher in the cut-off group with 97% than in the delta group at 86%. The risk that a TAPS is mistakenly not recognized prenatally is higher in the cut-off group than in the delta group (52% vs. 18%). Our data shows that delta MCA-PSV &gt; 0.5 MoM detects more cases of TAPS, which would not have been diagnosed prenatally according to the current guidelines. In the collective examined in the present study, TAPS diagnostics using delta MCA-PSV proved to be a more robust method.